Global Monovaccine (Epstein - Barr virus) Market is Estimated To Witness High Growth Owing To Increased R&D Investments
The global Monovaccine (Epstein - Barr virus) market comprises various products used for the prevention of mononucleosis caused by Epstein-Barr virus (EBV). The products help in boosting the body's immune system response against EBV. They find wide application among children and adolescents. The global Monovaccine (Epstein - Barr virus) market is estimated to be valued at US$ 10.42 Bn in 2023...
0 Comments 0 Shares 1K Views 0 Reviews
Sponsored